- Page 1 and 2: Haematology and Blood Transfusion 2
- Page 3 and 4: Dr. Rolf Neth, Universitäts-Kinder
- Page 5 and 6: Participants of the Meeting Adamson
- Page 7 and 8: Participants of the Meeting xv Knig
- Page 9 and 10: Wilsede Scholarship Holders (grante
- Page 11 and 12: xx Preface
- Page 13 and 14: Acknowledgement We should like to t
- Page 15 and 16: 4 Moloney. W. C. Fig.l Fig.2
- Page 17 and 18: 6 Moloney. w. C. Fig.5 Fig.6 genesi
- Page 19 and 20: 8 Gallo. R. C. though the age of ea
- Page 21 and 22: Table 1. Infectious primate type-C
- Page 23 and 24: 12 Gallo, R. C. some viruses and, i
- Page 25 and 26: Gallo. R. C. A. Hybridlzatioq ot Mu
- Page 27 and 28: 16 Gallo, R. C. patients HL-49 and
- Page 29 and 30: 18 GaIlo, R. C. conc1ude that the m
- Page 31 and 32: 20 Gallo. R. C. Fig.4. Morphologyof
- Page 33 and 34: 22 Gallo. R e. lespie. D. H .. Reit
- Page 35 and 36: 24 Gallo, R e. 46. Wolfe, L. G., De
- Page 37 and 38: 26 Pinkel, D. therapy; meningeal ir
- Page 39 and 40: 28 Pinkel. D. .!2.. 150 ...ll. 140_
- Page 41 and 42: 30 Pinkel, D. failure to eradicate
- Page 43 and 44: 32 PinkeL D. kemia cells and theref
- Page 45: Epidemiology of Leukemia Miller, R.
- Page 49 and 50: Epidemiology of Leukemia 41 12. Fun
- Page 51 and 52: 44 Rowley, J. D. contain the PhI ch
- Page 53 and 54: 46 Rowley, J. D. In regard to the s
- Page 55 and 56: 48 Rowley, J. D. icantly related to
- Page 57 and 58: 50 Rowley, J. D. mosomes with the g
- Page 59 and 60: 52 Rowley, J. D. 28. Rowley, 1. D.:
- Page 61 and 62: 54 Fialkow. P. J. cludes any hypoth
- Page 63 and 64: 56 Fialkow, P. J. using G-6-PD as a
- Page 65 and 66: 58 Fialkow, P. 1. 14. Maniatis, A.K
- Page 67 and 68: 60 Georgii. A. For these reasons th
- Page 69 and 70: 62 Georgii, A.
- Page 71 and 72: 64 Georgii, A.
- Page 73 and 74: 66 Georgii, A. Table 3. Values of c
- Page 75 and 76: 68 Georgii. A. chronic granulocytic
- Page 77 and 78: 70 Georgii, A. Rappaport, H.: Acute
- Page 79 and 80: 72 Gale, R. P. The human major hist
- Page 81 and 82: 74 Gale, R. P. Approximately 60-70
- Page 83 and 84: 76 Gale. R. P. Table 2. Leukemic re
- Page 85 and 86: 78 Gale, R. P. I I. Neiman, P. E.,
- Page 87 and 88: 80 Bekesi. J. G .. Holland. J. F. a
- Page 89 and 90: 82 Bekesi. 1. G .. Holland. J. F. u
- Page 91 and 92: 84 Bekesi. J. G .. Holland. 1. F. p
- Page 93 and 94: Bekesi. J. G.. Holland, J. F. 2 - X
- Page 95 and 96: Treatment of Adult Acute Myeloblast
- Page 97 and 98:
Treatment of Adult Acute Myeloblast
- Page 99 and 100:
Prediction of Therapeutic Jlesponse
- Page 101 and 102:
Prediction ofTherapeutic Response i
- Page 103 and 104:
Prediction ofTherapeutic Response i
- Page 105 and 106:
Prognostic Factors in Adult Acute L
- Page 107 and 108:
Prognostic Factors in Adult Acute L
- Page 109 and 110:
Prognostic Factors in Adult Acute L
- Page 111 and 112:
Prognostic Factors in Adult Acute L
- Page 113 and 114:
108 Catovsky. D. et al. Results The
- Page 115 and 116:
110 Catovsky. D. et al. Table 1. Mo
- Page 117 and 118:
112 Catovsky, D. et al. clear outli
- Page 119 and 120:
Intermediate Dose Methotrexate (IDM
- Page 122 and 123:
118 Freeman. A. I. et al. again at
- Page 124 and 125:
120 Freeman. A. I. et al. c: 90 o .
- Page 126 and 127:
122 Freeman. A I. et a!. A comparab
- Page 128 and 129:
122 Freeman. A. I. et al. A compara
- Page 130 and 131:
Marrow Terminal Deoxynucleotidyl Tr
- Page 132 and 133:
Marrow Terminal Deoxynucleotidyl Tr
- Page 134 and 135:
Marrow Terminal Deoxynucleotidyl Tr
- Page 136 and 137:
Clinical Significance ofTdT, Cell S
- Page 138 and 139:
CIinical Sigmificance ofTdT. Cell S
- Page 140 and 141:
Clinical Significance ofTdT. Cell S
- Page 142 and 143:
Clinical Significance ofTdT, Cell S
- Page 144 and 145:
Biochemical Determinants for Antile
- Page 146 and 147:
Biochemical Determinants for Antile
- Page 148 and 149:
Biochemical Determinants for Antile
- Page 150 and 151:
146 Chandra, P. et al. CYTOSINE o .
- Page 152 and 153:
148 Chandra, P. et al. 700 600 I 50
- Page 154 and 155:
150 Chandra, P. et al. 120 ~100 c:
- Page 156 and 157:
152 Chandra. P. et al. 100 000 ..,.
- Page 158 and 159:
154 Chandra, P. et al. WBC ~ MPC 0.
- Page 160 and 161:
Summary of Clinical Poster Sessions
- Page 162 and 163:
Summary of Clinical Poster Sessions
- Page 164 and 165:
Summary of Clinical Poster Sessions
- Page 166 and 167:
Progress in Acute Leukemia 1975-197
- Page 168 and 169:
Progress in Acute Leukemia 1975-197
- Page 170 and 171:
Progress in Acute Leukemia 1975-197
- Page 172 and 173:
Regulatory Interactions in Normal a
- Page 174 and 175:
Regulatory Interactions in Normal a
- Page 176 and 177:
Regulatory Interactions in Normal a
- Page 178 and 179:
Regulatory Interactions in Normal a
- Page 180 and 181:
Regulatory Interactions in Normal a
- Page 182 and 183:
Leukemic Inhibition ofNormal Hemato
- Page 184 and 185:
Leukemic Inhibition ofNormal Hemato
- Page 186 and 187:
Leukemic Inhibition ofNormal Hemato
- Page 188 and 189:
Leukemic Inhibition ofNormal Hemato
- Page 190 and 191:
Leukemic Inhibition ofNormal Hemato
- Page 192 and 193:
Clonal Diseases of the Myeloid Stem
- Page 194 and 195:
Clonal Diseases of the Myeloid Ster
- Page 196 and 197:
Clonal Diseases ofthe Myeloid Stern
- Page 198 and 199:
Clon al Diseases of the Myeloid Ste
- Page 200 and 201:
200 Greenberg. Po. Mara. B. granulo
- Page 202 and 203:
202 Greenberg. P .. Mara. B. rates
- Page 204 and 205:
204 Greenberg. P .. Mara. B. Heller
- Page 206 and 207:
206 Adamson. J. W. hibited only iso
- Page 208 and 209:
208 Adamson. J. W. endogenous colon
- Page 210 and 211:
210 Adamson. J. W. Acknowledgments
- Page 212 and 213:
212 Biermann. E. et al. Table 1. Cy
- Page 214 and 215:
214 Biermann. E. et al. Table 3. Qu
- Page 216 and 217:
Differentiation Ability of Peripher
- Page 218 and 219:
Differentiation Ability of Peripher
- Page 220 and 221:
Differentiation Ability of Peripher
- Page 222 and 223:
224 Dexter. T. M .. Teich. N. M ..
- Page 224 and 225:
Table 3. Biological effects ofinfec
- Page 226 and 227:
228 Dexter, T. M., Teich. N. M. "CF
- Page 228 and 229:
Characterization of Myelomonocytic
- Page 230 and 231:
Characterization of MyeIomonocytic
- Page 232 and 233:
Characterization of Myelomonocytic
- Page 234 and 235:
238 Yefenof. E. Using the quantitat
- Page 236 and 237:
242 Duesberg. P. et aL all, or part
- Page 238 and 239:
244 Ouesberg. P. et al. 2 A (e) MC2
- Page 240 and 241:
Duesberg. P. et a!. C 345 MC29{MCAV
- Page 242 and 243:
248 Ouesberg. P. et al. Table 2. Tr
- Page 244 and 245:
2S0 Duesberg. P. et al. Table 5. T
- Page 246 and 247:
252 Ouesberg. P. et al. Table 6. Hy
- Page 248 and 249:
254 Duesberg. P. et al. A c . 12 13
- Page 250 and 251:
256 Duesberg. P. et al. A B C 0 P 1
- Page 252 and 253:
258 Duesberg. P. et al. In vitro tr
- Page 254 and 255:
260 Duesberg. P. et al. 5. Hu. S. S
- Page 256 and 257:
262 Erikson. R. L. et al. The major
- Page 258 and 259:
264 Erikson. R. L. et al. Virus p60
- Page 260 and 261:
266 Erikson. R. L. et al. - 88K- Pr
- Page 262 and 263:
268 Erikson. R L. et al. concerning
- Page 264 and 265:
The in vitro Translation of Rous Sa
- Page 266 and 267:
The in vitro Translation of Rous Sa
- Page 268 and 269:
The in vitro Translation of Rous Sa
- Page 270 and 271:
Regulation of Translation of Eukary
- Page 272 and 273:
Regulation ofTranslation ofEukaryot
- Page 274 and 275:
Regulation ofTranslation of Eukaryo
- Page 276 and 277:
284 Kramer. G. et al. [ e1F-2 Mel-t
- Page 278 and 279:
286 Kramer. G. et al. Translational
- Page 280 and 281:
288 Kramer, G. et al. A B - 1234567
- Page 282 and 283:
290 Kramer, G. et al. 22. Levin, D.
- Page 284 and 285:
292 Kerr, I. M. et al. that we and
- Page 286 and 287:
294 Kerr. I. M. et al. being suffic
- Page 288 and 289:
296 Koch, G. et al. Labeling Of Cel
- Page 290 and 291:
298 Koch, G. et al. the RTE of the
- Page 292 and 293:
300 Koch. G. et al. zidine techniqu
- Page 294 and 295:
Inhibition of Polypeptide Chain Ini
- Page 296 and 297:
Inhibition of Polypeptide Chain Ini
- Page 298 and 299:
Possible Role of the Friend Virus L
- Page 300 and 301:
Possible Role of the Friend Virus L
- Page 302 and 303:
Possible Role ofthe Friend Virus Li
- Page 304 and 305:
314 Jones, C. Fig. 2. Demonstration
- Page 306 and 307:
316 Jones. C. Table 1. Characterist
- Page 308 and 309:
Effect of Vitamin A on Plasminogen
- Page 310 and 311:
Effect ofVitamin A on Plasminogen A
- Page 312 and 313:
Effect ofVitamin A on Plasminogen A
- Page 314 and 315:
326 Hardesty. B. Specific m RNA New
- Page 316 and 317:
328 Hardesty, B. of their "transfor
- Page 318 and 319:
330 Hardesty. B. cytes is held in a
- Page 320 and 321:
332 Hardesty. B. the normal control
- Page 322 and 323:
336 Greaves. M. F. Table 1. Markers
- Page 324 and 325:
338 T Li neage Tdt+ ALL+ 1 - T+ Pre
- Page 326 and 327:
340 Greaves. M. F. or 'Ia'-like ser
- Page 328 and 329:
342 Greaves. M. F. Table 3. Acute l
- Page 330 and 331:
344 Greaves, M. F Catovsky, D.: Mem
- Page 332 and 333:
Characterization of Antigens on Acu
- Page 334 and 335:
Characterization of Antigens on Acu
- Page 336 and 337:
Characterization of Antigens on Acu
- Page 338 and 339:
Common All Associated Antigen from
- Page 340 and 341:
Common All Associated Antigen from
- Page 342 and 343:
Common All Associated Antigen from
- Page 344 and 345:
Common All Associated Antigen from
- Page 346 and 347:
Common All Associated Antigen from
- Page 348 and 349:
Common All Associated Antigen from
- Page 350 and 351:
366 .. 0 . . ' 't ••• b c d B
- Page 352 and 353:
368 Brown, Go et al. Table 3. Genet
- Page 354 and 355:
370 Bach. F. H. et al. carry the Ly
- Page 356 and 357:
372 Bach, F. H. et al. dividual B i
- Page 358 and 359:
374 Bach. F. H. et al. Table 4. Lys
- Page 360 and 361:
376 Bach, F. H. et aI. 8. Solliday,
- Page 362 and 363:
378 Oliver. R. T. 0 .. Lee. S. K. g
- Page 364 and 365:
T Cell Function in Myelogenous Leuk
- Page 366 and 367:
T Cell Function in Myelogenous Leuk
- Page 368 and 369:
Recognition of Simian Sarcoma Virus
- Page 370 and 371:
Recognition of Simian Sarcoma Virus
- Page 372 and 373:
Recognition of Simian Sarcoma Virus
- Page 374 and 375:
Recognition ofSimian Sarcoma Virus
- Page 376:
Recognition ofSimian Sarcoma Virus
- Page 379 and 380:
396 Snyder, H. W .. Je. et aL 100 2
- Page 381 and 382:
398 Snyder, H. W., Jr. et al. the g
- Page 383 and 384:
A Search for Type-C Virus Expressio
- Page 385 and 386:
A Search for Type-C Virus Expressio
- Page 387 and 388:
Tumor Cell Mediated Degradation In
- Page 389 and 390:
Tumor CeH Mediated Degradation In V
- Page 391 and 392:
Tumor Cell Mediated Degradation In
- Page 393 and 394:
Evidence Supporting a Physiological
- Page 395 and 396:
Evidence Supporting a Physiological
- Page 397 and 398:
418 Witz, 1. P. to detect the corre
- Page 399 and 400:
420 Witz. I. P. against antigens as
- Page 401 and 402:
424 Weiss, R. A. Thus retroviruses
- Page 403 and 404:
426 Weiss, R. A. 60000 daltons that
- Page 405 and 406:
Mechanism of Leukemogenesis and of
- Page 407 and 408:
Mechanism ofLeukemogenesis and ofTa
- Page 409 and 410:
Mechanism of Leukemogenesis and ofT
- Page 411 and 412:
Mechanism ofLeukemogenesis and ofTa
- Page 413 and 414:
Mechanism ofLeukemogenesis and ofTa
- Page 415 and 416:
Infectious Leukemias in Domestic An
- Page 417 and 418:
Infectious Leukemias in Domestic An
- Page 419 and 420:
Infectious Leukemias in Domestic An
- Page 421 and 422:
Biochemical and Epidemiological Stu
- Page 423 and 424:
Biochemical and Epidemiological Stu
- Page 425 and 426:
Biochemical and Epidemiological Stu
- Page 427 and 428:
Biochemical and Epidemiological Stu
- Page 429 and 430:
Leukemia Specific Antigens: FOCMA a
- Page 431 and 432:
Leukemia Specific Antigens: FOCMA a
- Page 433 and 434:
Leukemia Specific Antigens: FOCMA a
- Page 435 and 436:
Leukemia Specific Antigens: FOCMA a
- Page 437 and 438:
Leukemia Specific Antigens: FOCMA a
- Page 439 and 440:
Leukemia Specific Antigens: FOCMA a
- Page 441 and 442:
Leukemia Specific Antigens: FOCMA a
- Page 443 and 444:
466 Essex. M. et a!. M .. Cotter. S
- Page 445 and 446:
A Single Genetic Locus Determines t
- Page 447 and 448:
A Single Genetic Locus Determines t
- Page 449 and 450:
A Single Genetic Locus Determines t
- Page 451 and 452:
A Single Genetic Locus Determines t
- Page 453 and 454:
A Single Genetic Locus Oetermines t
- Page 455 and 456:
A Single Genetic Locus Determines t
- Page 457 and 458:
A Single Genetic Locus Determines t
- Page 459 and 460:
484 Hillova. J .. Hill. M. Wong-Sta
- Page 461 and 462:
486 Hillova. J .. HilI. M. Referenc
- Page 463 and 464:
488 Teich. N. et al. Abelson virus
- Page 465 and 466:
490 Teich. N. et a!. these cell typ
- Page 467 and 468:
492 Nooter. K. et al. Table 1. Immu
- Page 469 and 470:
494 Nooter. K. et al. (6 of 17). Of
- Page 471 and 472:
496 Nooter. K. et al. human embryon
- Page 473 and 474:
498 Chandra. P. et al. Table 1. DNA
- Page 475 and 476:
500 Chandra. P. et al. References 1
- Page 477 and 478:
502 Jensen. F. C. ity. before and a
- Page 479 and 480:
The Role of Gene Rearrangement in E
- Page 481 and 482:
The Role ofGene Rearrangement in Ev
- Page 483 and 484:
The Role ofGene Rearrangement in Ev
- Page 485 and 486:
514 Cornelis. G. and, later, transf
- Page 487 and 488:
516 Cornelis. G. Fig. 2. Heterodupl
- Page 489 and 490:
518 Cornelis. G. D. Structure of th
- Page 491 and 492:
520 Cornelis. G. .Nllat 27.8 414 pG
- Page 493 and 494:
The Virus-Cell Gene Balance Model o
- Page 495 and 496:
The Virus-Cell Gene Balance Model o
- Page 497 and 498:
The Virus-Cell Gene Balance Model o
- Page 499 and 500:
530 Haseltine, W. A. et al. 5' 3' -
- Page 501 and 502:
532 Haseltine, W. A. et al. A . .
- Page 503 and 504:
534 Haseltine. W. A. et al. • A B
- Page 505 and 506:
Haseltine, W. A. et al. - m 0 B Akv
- Page 507 and 508:
538 Haseitine, W. A. et al. from th
- Page 509 and 510:
540 Haseltine. W. A. et al. • •
- Page 511 and 512:
542 Haseltine, W. A. et al. A Wl,.V
- Page 513 and 514:
Comparative Analysis ofRNA Tumor Vi
- Page 515 and 516:
548 • • c a b .... .' .. " -•
- Page 517 and 518:
550 Haseitine. W. A. et al. Table 4
- Page 519 and 520:
552 Haseltine, W. A. et al. Essex,
- Page 521 and 522:
554 Wong-Staal. F. et al. ofthe spl
- Page 523 and 524:
556 Wong-Staal. F. et aJ. a b c d e
- Page 525 and 526:
558 Wong-Staal. F. et al. Detection
- Page 527 and 528:
560 Wong-Staal. F. et al. ing HL23,
- Page 529 and 530:
562 Doehmer. J. et al. endogenous v
- Page 531 and 532:
564 Doehmer. J. et al. Table 1. Cor
- Page 533 and 534:
566 Doehmer. J. et al. Table 3. Seg
- Page 535 and 536:
568 Doehmer.1. et al. integration s
- Page 537 and 538:
570 Bacheier. L. T.. Fan. H. A 8 C
- Page 539 and 540:
572 Bacheier. L. T.. Fan. H. ABCDEF
- Page 541 and 542:
Release of Particle Associated RNA
- Page 543 and 544:
Release of Particle Associa ted RNA
- Page 545 and 546:
Release ofParticie Associated RNA D
- Page 547 and 548:
582 Boccara. M .. Kelly. F. Table 1
- Page 549 and 550:
584 Boccara. Mo. Kelly. F strain) a
- Page 551 and 552:
Summary of Meeting on Modem Trends
- Page 553 and 554:
Summary of Meeting on Modern Trends
- Page 555 and 556:
Subject Index Abelson virus, 425 -
- Page 557 and 558:
Subject Index - ofCFU-C, 211 Cytidi
- Page 559 and 560:
Subject Index - treatment with, 101
- Page 561 and 562:
Subject Index - promoting of, by vi
- Page 563:
Organ der Deutschen Gesellschaft f